Medicinal properties of Muntingia calabura L.: A Review

 

Arif Nur Muhammad Ansori1, Viol Dhea Kharisma2,3, Tridiganita Intan Solikhah4*

1Doctoral Program in Veterinary Science, Faculty of Veterinary Medicine,

Universitas Airlangga, Surabaya, Indonesia.

2Computational Virology and Complexity Science, Division of Molecular Biology and Genetics,

Generasi Biologi Indonesia Foundation, Gresik, Indonesia.

3Master Program in Biology, Department of Biology, Faculty of Mathematics and Natural Science,

Universitas Brawijaya, Malang, Indonesia.

4Division of Veterinary Clinic, Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, Indonesia.

*Corresponding Author E-mail: tridiganita-intan-s@fkh.unair.ac.id

 

ABSTRACT:

Indonesia has abundant medicinal plants, which have been historically used by the population in treating diseases for generations. Traditional Indonesian medicine and the medicinal plants used could lead to the discovery of novel drugs. For example, Muntingia calabura L., also known as kersen, is a well-known medicinal plant that has been used to treat various diseases worldwide. The pharmacological activities and phytochemical composition of the whole plant of M. calabura L. have been investigated and identified by scientists in recent decades. These studies have established the therapeutic potential of kersen for drug discovery. This present review provides an overview of the ethnopharmacology, pharmacology, and phytochemistry of M. calabura L. as they relate to its use against severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2).

 

KEYWORDS: Muntingia calabura L., Medicine , Pharmacology.

 

 


INTRODUCTION:

Indonesia has rich sources of natural medicines and traditional medicine preparations that have been used by most of the population for generations1,2,3. A direct advantage of traditional medicine formulations to the community is the ease of obtaining them4. The demand for plants used as traditional medicine formulations by the community is also increasing because plant-derived medicines have proven to be healthier and do not cause as many side effects as those derived from chemicals. However, a problem with traditional medicine formulations is the lack of adequate knowledge and information about the various types of plants commonly used as ingredients and their methods of use5.

 

Muntingia calabura L., also known as kersen, belongs to the family Muntingiaceae and is a fast-growing plant that is widely found worldwide6. M. calabura L. leaves have been considered by the population to be a medicinal plant and have properties including antidiabetic, anti-gout, antihypertensive, laxative, antiseptic, anti-seizure, gastroprotective, antioxidant, and anti-inflammatory activities as well as activity against productive cough, the flu, headache, and fever7,8,9. Furthermore, M. calabura L. leaves contain chemical compounds such as flavonoids, triterpenoids, tannins, saponins, and glycosides10,11.

 

The phytoconstituents of M. calabura stem bark consist of amino acids, flavonoids, saponins, proteins, triterpenoids, sterols, steroids, alkaloids, phenolic compounds, tannins, glycosides, and carbohydrates12. The nutritional value of M. calabura L. per gram of the leaves consists of 204.0±3.46mg carbohydrates, 002.04±0.15mg protein, and 001.41±0.07mg amino acids, whereas, that per gram of the fruit consists of 75.33±4.61mg carbohydrate, 06.44±0.15mg protein, and 00.88±0.07mg amino acids13. In addition, the pericarp of M. calabura also has many important health benefits8.

TAXONOMY:

The cherry plant has the Latin name M. Calabura L and in systematic taxonomy is classified as follows: kingdom, Plant; subkingdom: Tracheobionta; division: Spermatophyta; class: Dicotyledonae; subclass: Dialypetalae; order: Malvales; genus: Muntingia; species: Muntingia calabura L.14

 

PLANT DESCRIPTION:

M. calabura L. plants are shrubs that reach a height of 3-12m, with lined leaves and branches that hang down. The leaves are characteristically lanceolate with a smooth feathered surface, pointed tips, asymmetrical blunt base, jagged edges, and are 1.0-6.5cm wide and 2.5-15cm long. The flowers are white with a peculiar smell and slightly small. The fruit is initially green, turns bright red when it ripens, and its contents are runny with thousands of small yellow seeds with a diameter of 0.5 mm that are fully spread inside while the ripe fruit tastes sweet15.

 

GEOGRAPHICAL DISTRIBUTION:

Cherry plants (M. calabura L.) are fast growing with slender proportions and are often found flourishing on the side of the road. This plant is native to the Americas and is widely cultivated throughout Southeast Asia15. This plant has other names such as Jamaica cherry in the US, China cherry or Japan cherry in India, cherry chettu (Telugu)16, and Calabura in Brazil15.

 

ETHNOPHARMACOLOGY:

M. calabura L. is an herbal medicinal plant that is used to treat various health problems worldwide. The leaf is the main plant part of M. calabura L. commonly used to treat various diseases14.

 

PHYTOCHEMICAL COMPOSITION:

Table 1. Phytocomponents of Muntingia calabura L.

S. No.

Compound Name

Ref

1

(2S)-50-hydroxy-7,8,30,40-tetramethoxyflavan

17

2

Cabreuvin

17

3

7-hydroxyisoflavone

17

4

Isoliquiritigenin

17

5

20,40-dihydroxychalcone

17

6

5-hydroxy-3,7,8,40-tetramethoxyflavone

17

7

dihydroxy-3,7,8-trimethoxyflavone

17

8

5-hydroxy-3,7,8-trimethoxyflavone

17

9

Gnaphaliin

17

10

Ermanin

17

11

3,8-dimethoxy-5,7,40-trihydroxyflavone

17

12

Pinocembrin

17

13

8-methoxy-3,5,7-trihydroxyflavone

17

14

Chrysin

17

15

3,30-dimethoxy-5,7,40-trihydroxyflavone

17

16

7-hydroxyflavone

17

17

(2S)-7-hydroxyflavanone

17

18

Pinostrobin

17

19

Isokaemferide

17

20

Pinobanksin

17

 

BIOACTIVITIES:

Antibacterial Activity:

The study by Zakaria et al. (2006)18 showed that the aqueous extract of M. calabura L. leaves at 100.000ppm has antibacterial activity against Salmonella enteritidis, Citrobacter freundii, P. aeruginosa, Klebsiella pneumoniae, Vibrio cholerae, Pseudomonas aeruginosa, and Salmonella typhi bacteria. The study by Sibi et al. (2012)19 showed that the aqueous bark extract of this plant has antibacterial activity against P. aeruginosa, Bacillus cereus, and Micrococcus luteus. Furthermore, the aqueous leaf extract has antibacterial activity against M. luteus and P. aeruginosa while the aqueous fruit extract has antibacterial activity against M. luteus.

 

The methanol extract of M. calabura L. leaves at 100.000ppm has antimicrobial activity against C. freundii, K. pneumoniae, Vibrio cholerae, V. parahaemolyticus, and S. typhi bacteria18. The study by Sibi et al. (2012)19 showed that the methanol bark extract has antibacterial activity against B. cereus and M. luteus, the leaf extract had additional activity against P. aeruginosa, and the fruit extract was effective against Serratia marcescens. Furthermore, the study by Buhian et al. (2016)20 showed that the ethanol extracts of leaves and stems of M. calabura L. have antimicrobial activity against B. subtilis, Staphylococcus aureus, S. typhimurium, P. Aeruginosa, and Escherichia coli bacteria.

 

Antifungal Activity:

The ethanol extracts of M. calabura L. leaf and stem have antifungal activity against Candida albicans20. The methanol, chloroform, and petroleum ether extracts of M. calabura L. roots at a concentration of 100mg/mL have antifungal activity against Phytophthora sp., Colletotrichum sp., Alternaria solani, Pythium sp., Aspergillus niger, Fusarium oxysporum f.sp lycopersici, and Rhizoctonia solani21

 

Antihyperglycemic and Antidiabetic Activities:

Several studies have demonstrated the antihyperglycemic and antidiabetic activities of M. calabura L. For example. Aligita (2018)22 reported that at a dose of 400mg/kg body weight (BW), the aqueous leaf extract effectively reduced the blood glucose level, increased insulin sensitivity, and regenerated pancreatic β cells in a mouse model of type 2 diabetes. While other studies reported by Nugroho (2019)23 showed that the coadministration of M. calabura L. leaf extract and metformin at 300 and 45mg/kg BW, respectively effectively reduced the blood glucose levels in type 1 diabetic rats. In addition, the study by Sridhar et al. (2011)16 demonstrated that the methanolic extract of M. calabura L. leaves at a dose of 500mg/kg BW significantly reduced the blood glucose levels of diabetic rats.

Antinociceptive Activity:

Studies by Zakaria et al. (2007)24 showed that the aqueous extract of M. calabura L. leaves exhibited a heat-stable antinociceptive activity, which was partially mediated by an opioid receptor.

 

Antioxidant Activity:

In the study by Preethi et al. (2010)25, data analysis showed that the fruit extracts had high levels of antioxidant activity.

 

Anti-inflammatory activity:

The study by Mondal et al. (2013)26 showed that oral administration of 100, 250, and 500mg/kg BW of the ethanol extract of the stem bark showed significant anti-inflammatory activity. Moreover, the study by Gomathi et al. (2013)27 showed that oral administration of 200 and 400mg/kg BW of the polyphenol extracts of M. calabura L. fruit exhibited significant anti-inflammatory activity.

 

Antipyretic Activity:

Administration of 500mg/kg of M. calabura L. extract significantly decreased fever caused by yeast and this finding supports the view that the extract affects biosynthesis of prostaglandin, which is assumed to control body temperature26.

 

Anti-severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Activity:

Therapeutic agents that act on the coronavirus can be divided into several categories based on the specific pathways they affect. (1) Some agents act on enzymes or functional proteins that are critical to the virus, preventing viral RNA synthesis and replication. (2) Some agents acting on structural viral proteins to block the virus from binding to human cell receptors or inhibit the viral self-assembly process. (3) Some agents produce virulence factors that restore the host's innate immunity, and (4) some act on the host's specific receptors or enzymes, preventing the virus from entering host cells (Figure 1). On the other hand, Kharisma and Ansori (2020)28 reported the construction of epitope-based peptide vaccine against SARS-CoV-2. Ansori et al. (2020)29 characterized SARS-CoV-2 spike glycoprotein genes from Indonesia to investigate their genetic composition and variability.

 

Fig. 1. Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2) genome.

 

Traditional medicine is widely used worldwide and plants still constitute a large source of novel compounds with different bioactivities including anti-inflammatory, anticancer, antiviral, antibacterial, and cardioprotective. Antioxidants also play a health-promoting role30. However, there are no data on the activity of M. calabura L. against coronaviruses and we suggest that its phytocomponents should be tested via computational study (in silico), in vitro, and in vivo studies including on SARS-CoV-2 (Figure 2).

 

Fig. 2 Phytomedicinal benefits Muntingia calabura L. and against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2).

 

CONCLUSION:

In conclusion, ethnomedicinal and scientific reports on the medicinal properties of M. calabura L. exhibit it as a valuable plant and establish it as a candidate for future drug development against SARS-CoV-2.

 

ACKNOWLEDGEMENT:

This study was supported by the Directorate General of Higher Education, Ministry of Education and Culture of the Republic of Indonesia. We thank Editage for editing the manuscript.

 

CONFLICT OF INTEREST:

The authors declare no conflict of interest.

 

REFERENCES:

1.      Ansori ANM, et al. A review on medicinal properties of mangosteen (Garcinia mangostana L.). Research Journal of Pharmacy Technology. 2020; 13(2): 974–982.

2.      Khairullah AR, et al. A review of an important medicinal plant : Alpinia galanga (L.) willd. Syst Rev Pharm. 2020; 11(10): 387-395.

3.      Solikhah TI, et al. Antidiabetic activity of papaya leaf extract (Carica Papaya L.) isolated with maceration method in alloxan-induces diabetic mice. Syst Rev Pharm. 2020; 11(9): 774-778.

4.      Noer S, et al. (2018). Molecular identification of the medicinal herb plant Ruta angustifolia from Lembang Bandung using chloroplast DNA markers. AIP Conference Proceedings. 2018; 15.

5.      Srivastava JK, et al. Chamomile: A herbal medicine of the past with a bright future (Review). Molecular Medicine Reports. 2010; 3, 895–901.

6.      Yemineni M, et al. Preliminary phytochemical investigation and evaluation of hypoglycemic activity of ethanolic Extract of Muntingia calabura L. stem bark against normal and streptozotocin-induced diabetes. Asian Journal of Pharmaceutical and Clinical Research. 2019: 12(6): 1–6.

7.      Balan T, et al. Antioxidant and anti-inflammatory activities contribute to the prophylactic effect of semi-purified fractions obtained from the crude methanol extract of Muntingia calabura leaves against gastric ulceration in rats. Journal of Ethnopharmacology. 2014; (164): 1–15.

8.      Halim SZ, et al. Synergistic gastroprotective activity of methanolic extract of a mixture of Melastoma malabathricum and Muntingia calabura leaves in rats. BMC Complementary and Alternative Medicine. 2017; 17(488): 1–16.

9.      Herlina H, et al. Antidiabetic activity test of ethanolic seri leave’s (Muntingia calabura L.) extract in male rats induced by alloxan. 2018; 3(1): 7–13.

10.   Amiruddin ZZ. Free radical scavenging activity of some plants. Iranian Journal of Pharmacology and Therapeutics. 2007; 6: 87–91.

11.   Jisha N, et al. Anti-inflammatory efficacy of methanolic extract of Muntingia calabura L. leaves in Carrageenan induced paw edema model. Pathophysiology. 2019; 26(3-4): 323330.

12.   Safrida S, Sabri M. Effect of Muntingia calabura L. stem bark extracts on uric acid concentration and renal histopathology in diabetic rats. Medicina. 2019; 55(10): 695.

13.   Krishnaveni M and Dhanalakshmi R. Qualitative and quantitative study of phytochemicals in Muntingia calabura L. leaf and fruit. World Journal of Pharmaceutical Research. 2014; 3(6): 1687–1696.

14.   Mahmood ND, et al. Muntingia calabura: A review of its traditional uses, chemical properties, and pharmacological observations. Pharmaceutical Biology. 2014; 52:12, 1598–1623.

15.   Hawkeswood TJ, Sommung B. Pollination of Muntingia calabura L. (Muntingiaceae) by native bees in Bangkok, Thailand. Calodema. 2016; 421, 1–6.

16.   Sridhar M, et al. Antidiabetic effect of leaves of Muntingia calabura L. in normal and alloxan-induced diabetic rats. Pharmacologyonline. 2011; 2: 626–632.

17.   Su B, et al. Activity-guided isolation of the chemical constituents of Muntingia calabura using a quinone reductase induction assay. Phytochemistry. 2013; 63: 335–341.

18.   Zakaria ZA, et al. The in vitro antibacterial activity of Corchorus olitorius and Muntingia calabura extracts. Journal of Pharmacology and Toxicology. 2016; 1: 108–114.

19.   Sibi G, et al. Potential use of Muntingia calabura L. extracts against human and plant pathogens. Pharmacognosy Journal. 2012; 4(34), 44–47.

20.   Buhian WPC, et al. Bioactive metabolite profiles and antimicrobial activity of ethanolic extracts from Muntingia calabura L. leaves and stems. Asian Pacific Journal of Tropical Biomedicine. 2016; 6(8): 682–685.

21.   Ramasamy R, et al. Solvent extraction and evaluation of antifungal activity of Muntingia calabura root against fungal phytopathogens. International Journal of Current Microbiology and Applied Sciences. 2017; 6(7), 77–83.

22.   Aligita W, et al. Antidiabetic activities of Muntingia calabura L. leaves water extract in type 2 diabetes mellitus animal models. The Indonesian Biomedical Journal. 2018;10(2): 165–170.

23.   Nugroho, et al. Antidiabetic effect of combined Muntingia calabura L. leaf extract and metformin on rats. Proceedings of International Conference on Applied Science and Health. 2019; (4): 110–119.

24.   Zakaria ZA, et al. The antinociceptive action of aqueous extract from Muntingia calabura leaves: The role of opioid receptors. Medical Principles and Practice. 2007; 16: 130–136.

25.   Preethi K, et al. In vitro antioxidant activity of extracts from fruits of Muntingia calabura Linn. from India. Pharmacognosy Journal. 2010; 2(14): 11–18.

26.   Mondal S, et al. Investigation of analgesic, anti-inflammatory and antipyretic activities of ethanol extract from Muntingia calabura stem bark. Pharmawave. 2013; 6(13): 56–64.

27.   Gomathi R, et al. A dietary antioxidant supplementation of Jamaican cherries (Muntingia calabura L.) attenuates inflammatory related disorders. Food Science and Biotechnology. 2013; 22(3): 787–794.

28.   Kharisma VD, Ansori ANM. Construction of epitope-based peptide vaccine against SARS-CoV-2: Immunoinformatics study. Journal of Pure and Applied Microbiology. 2020; 14: 9991005.

29.   Ansori  ANM, et al. Genetic variant of SARS-CoV-2 isolates in Indonesia: Spike glycoprotein gene. Journal of Pure and Applied Microbiology. 2020; 14: 971978.

30.   Yan X, et al. Antioxidant activities and antitumor screening of extracts from cranberry fruit (Vaccinium macrocarpon). Journal of Agricultural and Food Chemistry. 2002; 50(21): 5844–5849.

 

 

 

Received on 01.07.2020           Modified on 17.08.2020

Accepted on 16.09.2020         © RJPT All right reserved

Research J. Pharm. and Tech. 2021; 14(8):4509-4512.

DOI: 10.52711/0974-360X.2021.00784